VanEck Pharmaceutical ETF (PPH)
NASDAQ: PPH
· Real-Time Price · USD
89.34
0.34 (0.38%)
At close: Sep 09, 2025, 3:59 PM
89.75
0.46%
After-hours: Sep 09, 2025, 05:12 PM EDT
0.38% (1D)
| Bid | 86.97 |
| Market Cap | 1.03B |
| AUM | 566.36M |
| NAV | 89.36 |
| EPS (ttm) | 4.14 |
| PE Ratio (ttm) | 21.58 |
| Shares Out | 11.55M |
| Inception Date | Dec 20, 2011 |
| Ask | 90.7 |
| Volume | 203.98K |
| Open | 88.72 |
| Previous Close | 89.00 |
| Day's Range | 88.63 - 89.43 |
| 52-Week Range | 77.67 - 98.30 |
| Holdings | 25 |
| Expense Ratio | 0.36% |
About PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol PPH
Inception Date Dec 20, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 72.57% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 17.12% |
| Johnson & Johnson | JNJ | 11.58% |
| Novartis Ag | NVS | 8.07% |
| Merck & Co., Inc. | MRK | 6.19% |
| Novo Nordisk A/s | NVO | 5.98% |
| Abbvie Inc. | ABBV | 5.08% |
| Astrazeneca PLC | AZN | 5.07% |
| Pfizer Inc. | PFE | 4.65% |
| Gsk Plc | GSK | 4.45% |
| Mckesson Corporation | MCK | 4.38% |
Dividends Dividend Yield 2.21%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jul 1, 2025 | $0.6069 | Jul 7, 2025 |
| Apr 1, 2025 | $0.5245 | Apr 4, 2025 |
| Dec 27, 2024 | $0.4110 | Dec 30, 2024 |
| Oct 1, 2024 | $0.4090 | Oct 4, 2024 |
| Jul 1, 2024 | $0.3558 | Jul 5, 2024 |
2 months ago · seekingalpha.com
PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And CenterI maintain a hold rating on PPH due to attractive valuation but weak technical momentum and underperformance versus the S&P 500. Eli Lilly and Johnson & Johnson, PPH's largest holdings, are facing uni...